Association between YKL-40 and asthma: a systematic meta-analysis
Authors:
- 16 October 2021
- journal article
- review article
- Published by Springer Nature in Sleep and Breathing
- Vol. 26 (3) , 1011-1022
Abstract
Purpose Many studies have shown that chitinase-3-like protein 1 (CHI3L1), also known as YKL-40, is associated with asthma. The purpose of this meta-analysis was to evaluate the role of serum YKL-40 in the diagnosis and differential diagnosis of asthma, severity grading, and determination of disease state. Methods The PubMed, Ovid, and Cochrane databases were searched. A total of 17 articles involving 5696 subjects were included in this meta-analysis. Results The results showed that the level of YKL-40 was significantly higher in asthmatic patients than in the normal group regardless of age and residential location, and increased with severity and acute exacerbation (p < 0.05). YKL-40 levels were significantly different between chronic obstructive pulmonary disease (COPD) and asthma, and also between asthma-COPD overlap syndrome (ACO) and asthma (p < 0.05). Conclusion YKL-40 may act as a potential serological marker for the diagnosis of asthma, assessment of severity, indicator of the disease state, and differential diagnosis of COPD, ACO, and asthma.Keywords
This publication has 45 references indexed in Scilit:
- The chitinase-like protein YKL-40: A possible biomarker of inflammation and airway remodeling in severe pediatric asthmaJournal of Allergy and Clinical Immunology, 2013
- Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural diseaseCytokine, 2012
- Role of Breast Regression Protein–39 in the Pathogenesis of Cigarette Smoke–Induced Inflammation and EmphysemaAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- The CHI3L1 rs4950928 polymorphism is associated with asthma-related hospital admissions in children and young adultsAnnals of Allergy, Asthma & Immunology, 2011
- YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Cancers, 2010
- YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin EEuropean Respiratory Journal, 2010
- Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosisJournal of Experimental Medicine, 2009
- Effect of Variation inCHI3L1on Serum YKL-40 Level, Risk of Asthma, and Lung FunctionNew England Journal of Medicine, 2008
- A Chitinase-like Protein in the Lung and Circulation of Patients with Severe AsthmaNew England Journal of Medicine, 2007
- Exoskeletons and ExhalationNew England Journal of Medicine, 2007